Septic shock with multiple organ failure is the leading cause of death in non-coronary intensive care units and remains a major health problem in the US. Endothelial cell dysfunction is an important hallmark of septic shock and results in increases in vascular permeability that play critical roles in the pathogenesis of multi-organ failure. Thus, improving endothelial function represents an important potential therapeutic target in sepsis. The long-term goal of our research is to identify novel treatment strategies for the endothelial injury of sepsis. The overall objective for this proposal is to identify the mechanisms by which endothelial progenitor cells (EPCs) modulate endothelial dysfunction in sepsis. EPCs are circulating, bone marrow-derived endothelial precursor cells which have been recently associated with sepsis. Specifically, EPCs from humans with sepsis demonstrate alterations in function compared to healthy controls and EPC proliferation is inversely related to organ dysfunction in human sepsis. Our data demonstrate that treatment with exogenous human cord blood derived EPCs improves survival, attenuates pulmonary vascular leak and improves organ injury in the murine cecal ligation and puncture (CLP) model of polymicrobial sepsis. A better understanding of the mechanisms by which EPCs exert their protective effects is crucial to the design of new therapeutic strategies. Endothelial cells (ECs) and EPCs are known to release exosomes and microparticles containing micro RNAs (miRNAs) that regulate endothelial function and barrier integrity. We have shown that treatment with EPCs alters circulating levels of EC relevant miRNAs in murine sepsis, including miR-126. Our findings provide strong evidence that miR-126 may play an important role in maintaining EPC/EC function and barrier integrity in sepsis. We propose two related hypotheses: 1) Endothelial progenitor cells regulate endothelial function and barrier integrity through release of specific miRNAs in sepsis and 2) Altered expression of miRNAs which regulate endothelial barrier integrity are associated with severity of illness and outcomes in human sepsis.
Two specific aims address these hypotheses:
Aim 1 : Determine the mechanisms by which EPCs affect vascular barrier integrity in murine sepsis.
Aim 2 : Determine the expression patterns of miRNAs known to modulate endothelial function and barrier integrity in human sepsis. The proposed research will lay a critical foundation for the design of novel therapeutic strategies for sepsis.

Public Health Relevance

Microvascular endothelial dysfunction is a hallmark of severe sepsis; however, there are no current therapies available to treat this life-threatening complication. The goal of this proposal is to determine the mechanisms by which endothelial progenitor cells (EPCs) improve endothelial barrier integrity in sepsis in order to identify novel treatment strategies for sepsis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM113995-04
Application #
9455737
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
2015-04-01
Project End
2020-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Pathology
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Fan, Hongkuan; Goodwin, Andrew J (2018) What's New in Shock, March 2019? Shock :
Li, Pengfei; Zhou, Yue; Goodwin, Andrew J et al. (2018) Fli-1 Governs Pericyte Dysfunction in a Murine Model of Sepsis. J Infect Dis 218:1995-2005
Jones Buie, Joy N; Zhou, Yue; Goodwin, Andrew J et al. (2018) Application of Deacetylated Poly-N-Acetyl Glucosamine Nanoparticles for the Delivery of miR-126 for the Treatment of Cecal Ligation and Puncture-Induced Sepsis. Inflammation :
Zhou, Yue; Li, Pengfei; Goodwin, Andrew J et al. (2018) Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis. Mol Ther 26:1375-1384
Goodwin, Andrew J; Ford, Dee W (2018) Readmissions Among Sepsis Survivors: Risk Factors and Prevention. Clin Pulm Med 25:79-83
Jones Buie, Joy N; Goodwin, Andrew J; Cook, James A et al. (2016) The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis 254:271-281
Goodwin, Andrew J; Guo, Changrun; Cook, James A et al. (2015) Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study. Crit Care 19:440
Li, Pengfei; Guo, Youming; Bledsoe, Grant et al. (2015) Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Crit Care 19:200